Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

UC San Diego Health Selects Model, Launches Its ACO

MEDICINE: System Is Betting On Treatment Strategies Success

UC San Diego Health has launched a Medicare program that brings the potential for health system savings — that is, if it can meet care and cost requirements.

Tease photo

Sempra, Oncor Deal Reportedly Poised to Receive Approval

San Diego-based Sempra Energy’s $9.45 billion acquisition of Texas energy giant Oncor appears headed for approval.

Ionis Licenses Kidney Drug in Deal Worth up to $330M

Carlsbad’s Ionis Pharmaceuticals has licensed a kidney drug to British giant AstraZeneca, earning $30 million upfront and the potential for $300 million in development and regulatory milestone payments.

AMN Healthcare Reports Solid Growth

Medical staffing company AMN Healthcare reported 2017 fourth quarter revenue of $509 million, a 4 percent year-over-year increase.

Technology Is Key Part of Workflow for Irrigation Company

MANUFACTURING: Its Acquisitions Boost Core Biz, Help Cover New Ground

It’s not uncommon to see sprinklers over-irrigate, turning yards into swamps — or spraying water while it’s raining.

Tease photo

Tandem Diabetes Care Gains Distribution Outside U.S.

San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.

Dexcom Pilot Program Targets Type 2 Diabetes Population

DEVICES: Company Gains Advantage By Partnering With Insurer

Dexcom aspires to widen its reach beyond Type 1 diabetes. Recently, the San Diego company took a big step toward the goal.

Tease photo

First Blood Test to Evaluate Concussions Receives Green Light

A first-ever test from San Diego’s Banyan Biomarkers to help doctors diagnose traumatic brain injuries has won Federal Drug Administration approval.

Neurocrine Reports Big Gains

San Diego biotech Neurocrine reported a big increase in revenue following the launch of a nervous system drug in late spring, according to financial results released Feb. 13.

Hospital Deal to Fuel Downtown Escondido Construction Boom

An Encinitas developer has struck a deal to buy Palomar Health’s downtown Escondido hospital campus for $18 million, paving the way for a mixed-use project that’s poised to be the epicenter of a construction boom in the area.

Tease photo

Tandem Diabetes Care Lists $60 Million Public Stock Offering

San Diego medical device maker Tandem Diabetes Care recently announced a $60 million public stock offering.

$775M Settlement Spares SDG&E

ENERGY: Utility Still on Hook For Part of San Onofre Costs

San Diego Gas & Electric’s bottom line won’t be impacted by a proposed settlement that will cut by $775 million owed by ratepayers for the closure of the San Onofre nuclear plant.

Sirenas Inks Research Partnership with Bristol-Myers Squibb

Sirenas, a marine-centric biotech in San Diego, has entered into a research agreement with pharmaceutical giant Bristol-Myers Squibb.

Dexcom CEO Is ‘Gadget Guy’ Who Emphasizes Human Side, Grows Co.

Seated beside an oval table in his office, Kevin Sayer squints to read a text on his phone. His blue eyes — the same color as his button-down shirt – light up.

Tease photo

MKO Global Partners Acquired

San Diego-based MKO Global Partners has been acquired by Two Labs, which provides product and commercialization services to pharmaceutical manufacturers.

Former Arcturus CEO Is Challenging His Termination

Joseph Payne is challenging the legality of Arcturus Therapeutics firing him as president and CEO of the company, according to a Feb. 6 letter filed with the U.S. Securities and Exchange Commission.

Hemp Companies Take Root in the Region

AG: Medical Use Explored; Retail Products Find Following

A so-called green rush in San Diego has centered on marijuana. But a crop of companies are capitalizing on a lesser-known part of the cannabis industry: hemp.

Tease photo

Industry Welcomes Suspension of Device Tax

HEALTH CARE: Tax Said to Hurt Staffing, R&D Efforts at Cos.

While San Diego’s medtech hub is cheering the recent suspension of a 2.3 percent excise tax on medical device makers, a full repeal remains the industry’s ultimate goal.

Tease photo

Oncor, Sempra Deal Receives Unanimous Stakeholder Support

Sempra Energy’s $9.45 billion deal to acquire Oncor has garnered unanimous support from 10 stakeholders involved in the regulatory proceedings, it was announced last week.

Arcturus Therapeutics Terminates CEO

The company said Feb. 2 that its board fired president and CEO Joseph Payne and named Mark Herbert as interim president.

OncoSec Announces $20 Million Public Stock Offering

OncoSec Medical, a San Diego biotech developing cancer therapies, announced on Feb. 1 a $20 million public stock offering.

Illumina Awarded $26.7M in Lawsuit

LEGAL: Patent Infringement Case Over Prenatal Testing

A federal jury in San Francisco awarded Illumina $26.7 million in a lawsuit accusing Ariosa Diagnostics of infringing on patents, a decision that could bolster Illumina’s strong position in the prenatal testing market.

Medical Director Named at Scripps MD Anderson Cancer Center

Thomas Buchholz, a physician, researcher and scholar, has been named medical director of the Scripps MD Anderson Cancer Center.

Medical Providers Target Areas Of Risk to Combat Opioid Abuse

MEDICINE: New Approach Includes Preemptive Efforts, Changes in Treatments

San Diego health systems have sought to lessen opioid prescriptions, from emergency rooms to cancer care.

Tease photo

Illumina’s Q4 Revenue Jump Beats Analysts’ Estimate

The San Diego genomics company posted fourth quarter revenue of $778 million, a 26 percent year-over-year increase.

Scripps Research Institute Receives Graduate Program Donation

Skaggs family foundations contributed a lead gift toward a $100 million campaign to establish fellowships for all students of The Scripps Research Institute’s graduate program.

Changing the Course Of Pain Management

Opioid Crisis Has Cos. Looking to Develop Safer Treatments

Some San Diego pharma and biotechs are rushing to market with alternatives to opioids, dependence on which mushroomed into a national health epidemic.

Tease photo

Illumina Awarded $26.7 Million in Patent Infringement Lawsuit

A federal jury in San Francisco awarded Illumina $26.7 million in a lawsuit accusing Ariosa Diagnostics, now owned by Roche, of infringing on two Illumina prenatal testing patents.

Palomar Health Lays Off 42 Employees in Reorganization

Palomar Health in North County has laid off 42 employees as part of a reorganization, citing a shifting health care landscape locally and nationally.

Reflexion Health, Greensboro Orthopaedics Partner on Virtual Rehabilitation Therapy

Under the deal, Reflexion’s FDA-cleared digital system, Vera, will be used as part of Greensboro’s postoperative rehabilitation program for total-joint replacement patients.

New UC San Diego Health Neurosurgery Department Chair Named

Dr. Alexander Khalessi has been tapped as chair of the Neurosurgery Department at UC San Diego Health.

Rady Family Foundation Pledges Up to $20M to Jewish Family Service

The pledge is part of the nonprofit’s $37 million centennial fundraising campaign.

Talks Over Sale of Hospital Site Appear to Be in Progress

Property: Local Developer a Contender For Escondido Campus

North County developer Integral Communities appears to be in talks with Palomar Health to redevelop a hospital campus that’s been a landmark of downtown Escondido since the 1950s.

Tease photo

University of St. Augustine for Health Sciences Names New President

Dr. Divina Grossman, who has more than 30 years of experience in higher education, is the new president of the University of St. Augustine for Health Services.

Tease photo

Every Detail Matters in Hospital Seismic Retrofit

CONSTRUCTION: Difficulties Abound in Medical Environment

Hospital earthquake planning has kept firms in San Diego like Degenkolb Engineers busy in recent years, the result of seismic retrofit deadlines drawing nearer.

Tease photo

ResMed Reports 13 Percent Revenue Increase in Q2

The San Diego company that makes devices and software for sleep issues reported that revenue rose to $601.3 million in the second quarter, a 13 percent year-over-year increase.

Scripps Health to Pay $1.5M in Settlement Over Improper Billing Claims

Scripps Health will pay $1.5 million to settle allegations related to improper billing for physical therapy services, according to the Justice Department.

Salk Partners with Indiviumed

The Salk Institute in San Diego has entered into a multi-year partnership with the cancer research company Indivumed, with the goal of turning research into medical applications.

Illumina to Open Up Market With More Affordable Sequencing

For Illumina, a fairly big announcement recently stemmed from a relatively compact box.

Tease photo

Luna DNA Seeks to Blaze New Trail to Data

BIOTECH: Co. to Use Blockchain, Cryptocurrency to Build Database

Dawn Barry recently came on board as president of the startup led by former Illumina executives like herself.

Tease photo

UC San Diego Health, Eisenhower Health Deal Expands Cancer Services

The agreement will expand cancer clinical trials and treatment options in the Coachella Valley.

Edico Brings Its Speed, Capacity to the Clinic

BIOTECH: Platform Interprets Genetic Data for Targeted Cures

The falling cost of sequencing genomes will generate a data tsunami. Edico Genome stands to make sense of much of it.

Tease photo

UnitedHealthcare Taps DexCom for Diabetes Management

Dexcom’s technology consists of a sensor that reads glucose levels just beneath the skin.

ERs Try Senior Focus For Proactive Medicine

HEALTH: Aim Is to Prevent Likely Problems, Cut Costs

Amid an aging population, San Diego hospitals have developed senior-focused emergency department services to improve care, with an eye toward their bottom lines.

Tease photo

Armed With $100M, Former Receptos Executives Launch New Biotech

In 2015, San Diego’s Receptos sold to Celgene for $7.2 billion. Rather than take it easy or go their separate ways, two Receptos’ executives immediately talked of getting the band back together.

Tease photo

DexCom Reports Big Increase in Q4 Revenue

The glucose monitoring company's unaudited revenue was $218 million during quarter ending Dec. 31.

Celgene to Buy Impact Biomedicines in $7B Deal

Impact Biomedicines was formed around reviving fedratinib, a drug intended to treat a bone marrow disorder and blood cancer.

Ziyen Energy Wins Drilling Contract

The company, formed in 2017, is focused on advanced oil extraction methods.

Arcturus Therapeutics, CureVac Announce Collaboration

The companies' first joint therapy will target a genetic disease marked by ammonia accumulating in the blood.

Illumina, KingMed Partner to Develop Sequencing Technology for China

Illumina called the collaboration a “significant step” toward China Food and Drug Administration review and approval.

Prev